[Prevention of facial herpetic infections after chemical peel and dermabrasion: new treatment strategies in the prophylaxis of patients undergoing procedures of the perioral area].
Angel
S
S
Boineau-Géniaux
D
D
Salag
P
P
Trepsat
F
F
Chosidow
O
O
Perrot
J L
JL
Will
F
F
Grognard
C
C
D015075:2-Aminopurine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D002615:Chemexfoliation / Q000009:adverse effects*; D018890:Chemoprevention / Q000191:economics / Q000706:statistics & numerical data; D003869:Dermabrasion / Q000009:adverse effects*; D019557:Dermatitis, Perioral / Q000209:etiology / Q000517:prevention & control*; D017558:Elective Surgical Procedures / Q000191:economics; D000077595:Famciclovir; D005260:Female; D005602:France; D006561:Herpes Simplex / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D012008:Recurrence; D013283:Stomatitis, Herpetic / Q000209:etiology / Q000517:prevention & control; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000998:Antiviral Agents; D015075:2-Aminopurine; D014633:Valine; D000077483:Valacyclovir; D000077595:Famciclovir; D000212:Acyclovir